• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Repros Therapeutics Inc. (RPRX)

    -NasdaqCM
    8.88 Up 0.24(2.78%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:8.64
    Open:8.60
    Bid:6.55 x 100
    Ask:N/A
    1y Target Est:26.83
    Beta:-1.7
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:8.60 - 9.10
    52wk Range:5.92 - 22.57
    Volume:278,374
    Avg Vol (3m):1,029,950
    Market Cap:215.57M
    P/E (ttm):N/A
    EPS (ttm):-1.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RPRXUp 2.78%215.57M
    ABTDown 0.04%68.81B
    ACTDown 0.66%67.38B
    AUXLUp 0.53%1.75B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.38
    Quarterly EPS Est (Dec-14) :-0.31
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback